TCI Co

TCI Co Debt/EBITDA

The Total Debt to EBITDA Ratio of TCI Co (8436.TWO) as of Oct 28, 2026 is 0.58. In the previous year, Total Debt to EBITDA Ratio was 1.67 — a change of -65.05% (lower).

Debt/EBITDA

0.58

YoY

-65.05%

Last updated:

Total Debt to EBITDA Ratio of TCI Co is 2025 0.58 . Total Debt to EBITDA Ratio of TCI Co was 2024 1.67 . It decreases by -65.05% lower compared to the previous year.

The TCI Co Debt/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt/EBITDA
Date
Debt/EBITDA
Jan 1, 2018
0.24 TWD
Jan 1, 2019
0.29 TWD
Jan 1, 2020
0.72 TWD
Jan 1, 2021
1.22 TWD
Jan 1, 2022
1.60 TWD
Jan 1, 2023
1.34 TWD
Jan 1, 2024
1.67 TWD
Jan 1, 2025
0.58 TWD
The TCI Co Debt/EBITDA history
YEARDebt/EBITDAYoY
0.58-65.05%
1.67+24.20%
1.34-16.27%
1.60+30.99%
1.22+68.61%
0.72+146.09%
0.29+21.86%
0.24+50.29%
0.16-58.13%
0.38-72.23%
1.38-54.23%
3.02—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

TCI Co Stock analysis

What does TCI Co do? TCI Co., Ltd. generates revenue through the research, development, manufacturing, and sales of health foods and care products. The company offers health foods in formats like hard capsules, soft capsules, pastilles, powder, liquid packs, jelly, and oil-based hard gelatine. Beauty care products include facial masks, eye masks, facial cleansers, anti-acne gel, whitening cream, slimming cream, breast enhancement cream, and serum. Additionally, TCI Co., Ltd. produces and sells biological products, medical devices, and confidential chemical materials. Domestic and overseas markets are the primary sales channels for these products. The company's health food segment targets consumers seeking dietary supplements and wellness solutions, while beauty care products cater to individuals focused on skincare and cosmetic enhancement. Biological products, medical devices, and confidential chemical materials serve healthcare providers and industrial clients. TCI Co., Ltd. distributes its offerings through established domestic distribution networks and international partnerships, focusing on markets where demand for health and beauty solutions is growing. TCI Co., Ltd. leverages its product portfolio to address diverse consumer needs across health and beauty categories. The firm's manufacturing capabilities enable it to produce a wide range of formats and formulations, supporting both retail and professional markets. By maintaining a presence in both domestic and overseas markets, TCI Co., Ltd. ensures consistent revenue streams from multiple geographic segments. TCI Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about TCI Co stock

Total Debt to EBITDA Ratio of TCI Co is 0.58 in 2025.

Total Debt to EBITDA Ratio of TCI Co changed from 1.67 to 0.58, representing a -65.05% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Debt to EBITDA Ratio TCI Co since 2006 – with annual values, charts, and detailed analysis.

Debt/EBITDA measures total debt relative to earnings before interest, taxes, depreciation, and amortization. It indicates the years needed to repay all debt from EBITDA.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Total Debt to EBITDA Ratio's TCI Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — TCI Co

All Key Metrics — TCI Co